Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v3-EN
Language English English
Date Updated 2018-04-10 2018-03-15
Drug Identification Number 02141019 02141019
Brand name CALCIUM GLUCONATE INJECTION, USP 10% CALCIUM GLUCONATE INJECTION, USP 10%
Common or Proper name Calcium Gluconate Injection USP 10% 100 mg/mL Calcium Gluconate Injection USP 10% 100 mg/mL
Company Name FRESENIUS KABI CANADA LTD FRESENIUS KABI CANADA LTD
Ingredients CALCIUM GLUCONATE CALCIUM SACCHARATE CALCIUM GLUCONATE CALCIUM SACCHARATE
Strength(s) 94MG 4.5MG 94MG 4.5MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 mL Vial 10 mL Vial
ATC code B05XA B05XA
ATC description I.V. SOLUTION ADDITIVES I.V. SOLUTION ADDITIVES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2018-03-14 2018-03-14
Actual start date
Estimated end date 2018-04-04 2018-04-04
Actual end date 2018-04-09
Shortage status Resolved Actual shortage
Company comments Please note that our 50ml and 100mLvials have been placed on allocation to ensure continuity of supply until we are back with our 10mL vials.
Health Canada comments